-
Mashup Score: 91
Adjuvant therapy with durvalumab, with or without tremelimumab, may have efficacy in patients with limited-stage small-cell lung cancer who do not have disease progression after standard concurrent…
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 87
Adjuvant therapy with durvalumab, with or without tremelimumab, may have efficacy in patients with limited-stage small-cell lung cancer who do not have disease progression after standard concurrent…
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4033rd Annual Mayo Clinic Hematology/Oncology Reviews 2024 | Mayo Clinic School of Continuous Professional Development - 4 month(s) ago
July 25 – 27, 2024 – The Ritz-Carlton Amelia Island – Amelia Island, Florida This course offers Live (in-person) and Livestream (virtual) attendance options. Mayo Clinic’s 33rd Annual Hematology/Oncology Reviews 2024 in Amelia Island, Florida is a comprehensive review of hematology/oncology that focuses on the application of new clinical and research advancements and
Source: ce.mayo.eduCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 51Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC | NEJM - 5 month(s) ago
Amivantamab plus lazertinib (amivantamab–lazertinib) has shown clinically meaningful and durable antitumor activity in patients with previously untreated or osimertinib-pretreated EGFR (epidermal g…
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 50Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC | NEJM - 5 month(s) ago
Amivantamab plus lazertinib (amivantamab–lazertinib) has shown clinically meaningful and durable antitumor activity in patients with previously untreated or osimertinib-pretreated EGFR (epidermal g…
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 16SUMMARY - OncLive/State of the Science Summit/Lung Cancer/Ft. Lauderdale, FL/June 26, 2024 - 5 month(s) ago
OncLive® State of the Science Summit: Disease State, Month Day, Year. Oncology live event features research and clinical advances in oncology.
Source: event.onclive.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 51Launching an International Community of Practice in Hematology/Oncology Medical Education - 6 month(s) ago
A community of practice (CoP) is a group of people who share a concern or a passion for something they do and learn how to do it better as they interact regularly. While the field of hematology/oncology has historically prioritized clinical care and biomedical research, medical education has received increasing attention within hematology/oncology in recent years. In 2018, ASCO launched the Education Scholars Program to train hematology/oncology clinicians in the science of teaching and learning. However, the number of hematology/oncology educators nationally and internationally far exceeds the capacity of the Education Scholars Program to train them. In addition, hematology/oncology educators often lack sufficient mentorship and guidance at their own institutions to pursue their chosen career path effectively. To ensure high-quality clinical care and research for generations to come, attention must be paid to improving support for hematology/oncology educators. Therefore, supported by
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 52Leveraging Multidisciplinary Care for Locally Advanced NSCLC - 6 month(s) ago
A Case-Based Panel Session will provide a practical framework and multiple physician perspectives for leveraging multidisciplinary care and improving treatment decision-making for locally advanced NSCLC.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
🚨🔥@OncoAlert Hot off the press. Thank you #ASCODailyNews @ASCO for this article promoting: Upcoming #ASCO24 Case-Based Panel #LungCancer #EducationSession, I’m honored to chair, joined by GREAT EXPERTS @DoctorJSpicer @HenryParkMD @Dingemans_AnneM 👇🏼 https://t.co/qS5ajj3CMX https://t.co/LVHbSSsb0U https://t.co/V2S0MNhrQh
-
-
Mashup Score: 49Launching an International Community of Practice in Hematology/Oncology Medical Education - 6 month(s) ago
A community of practice (CoP) is a group of people who share a concern or a passion for something they do and learn how to do it better as they interact regularly. While the field of hematology/oncology has historically prioritized clinical care and biomedical research, medical education has received increasing attention within hematology/oncology in recent years. In 2018, ASCO launched the Education Scholars Program to train hematology/oncology clinicians in the science of teaching and learning. However, the number of hematology/oncology educators nationally and internationally far exceeds the capacity of the Education Scholars Program to train them. In addition, hematology/oncology educators often lack sufficient mentorship and guidance at their own institutions to pursue their chosen career path effectively. To ensure high-quality clinical care and research for generations to come, attention must be paid to improving support for hematology/oncology educators. Therefore, supported by
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 47Launching an International Community of Practice in Hematology/Oncology Medical Education - 6 month(s) ago
A community of practice (CoP) is a group of people who share a concern or a passion for something they do and learn how to do it better as they interact regularly. While the field of hematology/oncology has historically prioritized clinical care and biomedical research, medical education has received increasing attention within hematology/oncology in recent years. In 2018, ASCO launched the Education Scholars Program to train hematology/oncology clinicians in the science of teaching and learning. However, the number of hematology/oncology educators nationally and internationally far exceeds the capacity of the Education Scholars Program to train them. In addition, hematology/oncology educators often lack sufficient mentorship and guidance at their own institutions to pursue their chosen career path effectively. To ensure high-quality clinical care and research for generations to come, attention must be paid to improving support for hematology/oncology educators. Therefore, supported by
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
🚨🔥 1/2 @OncoAlert Hot off the press. Just published @NEJM in conjunction with presentation on updated data @myESMO #ESMO2024 Results of #ADRIATIC trial of #Durvalumab vs #Placebo after #Chemoradiotherapy in Limited-Stage #SmallCell #LungCancer. 👇🏼 https://t.co/ElbWrwddii https://t.co/c6DTq1DORo